About Us

share on google plus
Text size
view with small font size
view with medium font size
view with large font size

Kyowa Hakko Kirin at a Glance

Who we are

Kyowa Hakko Kirin is a R&D-based pharmaceutical company with special strengths in biotechnology.

The Kyowa Hakko Kirin Group companies strive to contribute to the health and well-being of people around the world by creating new value through the pursuit of advances in life sciences and technologies.

Our Business Fields

  • Kyowa Hakko Kirin/ Ethical Drugs
  • Kyowa Hakko Bio/ Bio-Chemicals
  • Kyowa Medex/ Diagnostics
  • FUJIFILM KYOWA KIRIN BIOLOGICS/ Biosimilars

Our Business Strategy

Kyowa Hakko Kirin will further strengthen competitiveness in Japan through our category-based strategy. Category-based strategy applies to following four disease area:

  • Nephrology
  • Oncology
  • Immunology&Allergy
  • Central Nervous System

PDF file:New window opensFY2016-2020 Mid-term Business Plan(1,694KB)

Products

Kyowa Hakko Kirin’s products are all produced using cutting-edge manufacturing technology and equipment and under our strict quality assurance system and in full compliance with global standards.

Our Heritage

Kyowa Hakko Kirin is a pharmaceutical company, formed from a combination of the depth of experience and strong business record of Kyowa Hakko and Kirin Pharma.

R&D

Kyowa Hakko Kirin is working to discover and create new ways to improve wellness and treat disease with a special focus on:

  • Oncology
  • Nephrology
  • Immunology and allergy

Kyowa Hakko Kirin also undertakes drug discovery and try new approaches especially on:

  • Therapeutic antibodies
  • Small molecule drugs
  • Nucleic acid drugs

Related Links:

Kyowa Hakko Kirin Investors Relations

Current or prospective investors can find information on stock and Kyowa Hakko Kirin, corporate governance, financials, links to events and presentations.

To Page Top